Literature DB >> 8758044

Survivors of acute renal failure who do not recover renal function.

S Bhandari1, J H Turney.   

Abstract

Overall survival in 1095 patients with severe acute renal failure (ARF) between 1984 and 1995 was 59.5%. Of these, 107 (16.2%) remained dependent on long-term dialysis. The frequency of end-stage renal failure (ESRF) in survivors of ARF varied between 3% and 41% according to the cause of ARF, being highest in those with acute renal parenchymal disease (in whom survival was also among the highest at 84%) and lowest in ARF due to obstetrics and trauma. Patients failing to regain adequate renal function did not appear to differ on clinical grounds from survivors who became dialysis-independent. Survival in those requiring long-term dialysis was less good than for other patients with ESRF, partly due to excess mortality in those for whom vascular disease or surgery was the precipitating cause of ARF. Six patients recovered sufficient renal function to become independent of dialysis after 3-18 months on regular dialysis therapy (6-21 months after onset of ARF). ESRF resulting from ARF is more frequent than previously reported. This increase may be due to a changing case-mix, increasing age of patients (and hence reduced capacity for renal recovery), and an increase in aggressive surgery for patients with advanced vascular disease. This presents a significant and increasing problem, with implications for both clinical management and the provision of dialysis services.

Entities:  

Mesh:

Year:  1996        PMID: 8758044     DOI: 10.1093/qjmed/89.6.415

Source DB:  PubMed          Journal:  QJM        ISSN: 1460-2393


  28 in total

1.  Mortality and Recovery Associated with Kidney Failure due to Acute Kidney Injury.

Authors:  Silvi Shah; Anthony C Leonard; Kathleen Harrison; Karthikeyan Meganathan; Annette L Christianson; Charuhas V Thakar
Journal:  Clin J Am Soc Nephrol       Date:  2020-06-17       Impact factor: 8.237

2.  Urinary biomarkers and renal recovery in critically ill patients with renal support.

Authors:  Nattachai Srisawat; Xiaoyan Wen; Minjae Lee; Lan Kong; Michele Elder; Melinda Carter; Mark Unruh; Kevin Finkel; Anitha Vijayan; Mohan Ramkumar; Emil Paganini; Kai Singbartl; Paul M Palevsky; John A Kellum
Journal:  Clin J Am Soc Nephrol       Date:  2011-07-14       Impact factor: 8.237

Review 3.  DNA repair in ischemic acute kidney injury.

Authors:  Jeffrey D Pressly; Frank Park
Journal:  Am J Physiol Renal Physiol       Date:  2016-12-07

Review 4.  [Acute kidney injury].

Authors:  H Schmid; H Schiffl; S R Lederer
Journal:  Med Klin Intensivmed Notfmed       Date:  2012-03-23       Impact factor: 0.840

5.  CDK4/6 inhibition induces epithelial cell cycle arrest and ameliorates acute kidney injury.

Authors:  Derek P DiRocco; John Bisi; Patrick Roberts; Jay Strum; Kwok-Kin Wong; Norman Sharpless; Benjamin D Humphreys
Journal:  Am J Physiol Renal Physiol       Date:  2013-12-11

Review 6.  Multi-organ renal failure in the elderly.

Authors:  G H Neild
Journal:  Int Urol Nephrol       Date:  2001       Impact factor: 2.370

7.  Clinical cause of presumed acute tubular necrosis requiring renal replacement therapy and outcome of critically ill patients: post hoc analysis of a prospective 7-year cohort study.

Authors:  H Schiffl; R Fischer
Journal:  Int Urol Nephrol       Date:  2011-05-28       Impact factor: 2.370

Review 8.  Promoting Kidney Function Recovery in Patients with AKI Requiring RRT.

Authors:  Jorge Cerdá; Kathleen D Liu; Dinna N Cruz; Bertrand L Jaber; Jay L Koyner; Michael Heung; Mark D Okusa; Sarah Faubel
Journal:  Clin J Am Soc Nephrol       Date:  2015-07-02       Impact factor: 8.237

9.  [Acute renal failure. Extracorporeal therapy].

Authors:  J T Kielstein; D Fliser
Journal:  Internist (Berl)       Date:  2007-08       Impact factor: 0.743

10.  Nonrecovery of kidney function and death after acute on chronic renal failure.

Authors:  Chi-yuan Hsu; Glenn M Chertow; Charles E McCulloch; Dongjie Fan; Juan D Ordoñez; Alan S Go
Journal:  Clin J Am Soc Nephrol       Date:  2009-04-30       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.